Christi Shaw Eli Lilly & CO (LLY) insider trading activity

Christi Shaw is SVP and Pres., Lilly Bio-Meds of ELI LILLY & Co. Currently has a direct ownership of 0 shares of LLY, which is worth approximately $0. The most recent transaction as insider was on May 03, 2019, when has been sold 7,577 shares (Common Stock) at a price of $117.54 per share, resulting in proceeds of $890,601. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Christi Shaw Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 03 2019	SELL Open market or private sale	$890,601 $117.54 p/Share	7,577 Reduced 100.0%	0 Common Stock
May 01 2019	SELL Payment of exercise price or tax liability	$722,488 $117.04 p/Share	6,173 Reduced 44.89%	7,577 Common Stock
May 01 2019	BUY Exercise of conversion of derivative security	-	13,750 Added 50.0%	13,750 Common Stock
May 29 2018	SELL Open market or private sale	$691,775 $82.1 p/Share	8,426 Reduced 100.0%	0 Common Stock
May 01 2018	SELL Payment of exercise price or tax liability	$431,617 $81.07 p/Share	5,324 Reduced 38.72%	8,426 Common Stock
May 01 2018	BUY Exercise of conversion of derivative security	-	13,750 Added 50.0%	13,750 Common Stock

Also insider at

BEAM

Beam Therapeutics Inc. Healthcare

AVTR

Avantor, Inc. Basic Materials

Director

KYTX

Kyverna Therapeutics, Inc.

Christi Shaw

SVP and Pres., Lilly Bio-Meds

Indianapolis, IN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LLY shares.

Notify only if

Value

Insider Trading

Get notified when an Eli Lilly & CO insider buys or sells LLY shares.

Notify only if

Operation

Value

Type

News

Receive news related to ELI LILLY & Co

Track Activities on LLY

Account